This $870,886 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the development of a subunit vaccine against Babesiosis caused by Babesia microti at Tufts Medical Center Parent, Inc., a non-profit academic medical center in Boston, MA. The 3-year award, which began on September 1, 2023, will fund research efforts to create a new vaccine to prevent this tick-borne illness that can affect military personnel and the general public. As a major academic medical institution, Tufts Medical Center has received numerous federal grants and contracts to support its biomedical research and healthcare delivery missions. This latest award reflects the organization's expertise in vaccine development and its strategic partnership with the Department of Defense to address critical military medical needs.